期刊文献+

中国汉族人群IL-1 RA基因多态性及其与宫颈癌的相关性研究 被引量:3

Interleukin-1 Receptor Antagonist (IL-1 RA) Gene Polymorphism in Chinese Han Population and Association Study with Cervical Cancer
下载PDF
导出
摘要 目的研究位于白细胞介素1受体拮抗剂基因(interleukin-1receptorantagonist,IL-1RA)第2内含子中可变串联重复序列(variablenumberoftandemrepeats,VNTR)多态性在中国3个汉族人群中的分布情况,并探讨其与宫颈癌的发生关系。方法采用PCR方法分别对3个汉族人群206例个体以及42例宫颈癌患者和45例对照进行多态性检测,扩增产物进行2%的琼脂糖电泳。结果3个汉族群体的基因型以A1/A1和A1/A2最为常见。等位基因以A1频率最高,A2次之,群体间的差异是不显著的(P>0·05)。与美、英高加索人群相比,A1的频率明显偏高,A2明显偏低,而与非洲黑人相近。在宫颈癌患者和正常对照人群中,该多态位点的等位基因和基因型频率均无统计学意义(P>0·05)。结论IL-1RA第2内含子中VNTR多态性在不同种族间的分布存在着明显的差异,但与中国东北地区宫颈癌的发生可能无直接相关性。 Objective To investigate the distribution of polymorphisms of the variable number of tandem repeats (VNTR) at intron 2 of interleukin-1 receptor antagonist ( IL- 1RA ) gene in Chinese three Han populations and relationship with pathogenesis of cervical cancer. Methods The specific fragments were amplified by polymerase chain reaction (PCR) and were detected by running the amplicons on 2% agarose gel for 206 healthy subjects from Xinjiang, Fujian, Sichuan province and 42 patients with cervical cancer and 45 normal controls. Results A1 /A1 and A1/A2 were the common genotypes in Chinese three Hart populations. A1 was the most frequent one and A2 the second, there was no difference among Chinese three Han populations ( P 〉 0.05). Compared with American and En- gland Caucasians, the frequency of A 1 in Chinese three Han populations was higher, while A2 lower, which was similar with Black South Mrican. No difference was observed between the cervical cancer groups and the controls with respect to both the allele and genotype frequency of the IL- 1 RA gene polymorphisms. Conclusion IL- 1 RA intron 2 VNTR gene polymorphism were different in different ethnic populations, and might not be associated with cervical cancer in Chinese Northeast district.
出处 《国际遗传学杂志》 CAS 2006年第3期164-168,共5页 International Journal of Genetics
基金 国家自然科学基金资助项目(No.39993420) 教育部高等学校博士学科点专项科研基金(No.20040226001)
关键词 IL-1RA VNTR 基因多态性 宫颈癌 IL- 1 RA VNTR Gene polymorphism Cervical cancer
  • 相关文献

参考文献21

  • 1Arend WP,Malyak M,Guturidgeo CJ,et al.Interleukin-1 antagonist:role in biology.Annu Rev Immunol,1998,16:27-55.
  • 2Arend WP.Interleukin-1 receptor antagonist:a new member of the interleukin-1 family.J Clin Invest,1991,88:1445-1451.
  • 3Arend WP.Interleukin-1 receptor antagonist:discovery,structure and properties.Prog Growth Factor Res,1990,2:193-205.
  • 4Dinarello CA.Biologic basis for interleukin-1 in disease.Blood,1996,87:2095-2147.
  • 5Witkin SS,Gerber S,Ledger WJ.Influence of interleukin-1 receptor antagonist gene polymorphism on disease.Clin Infect Dis,2002,34:204-209.
  • 6连丽娟.林巧稚妇科肿瘤学(第2版)[M].北京:人民卫生出版社,1994.533-544.
  • 7Castello G,Espositio E,Stellato G,et al.Immunological abnormalities in patients with cervical carcinoma.Ginecol Oncol,1986,25:61-64.
  • 8Schwartz LB,Cargangiu ML,Bradham L,et al.Rapidly progressive squamous cell carcinoma coexisting with human immunodeficiency virus infection:clinical opinion.Ginecol Oncol,1991,41:255-258.
  • 9Tarlow JK,Blackmore AIF,Lennard A.Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86bp tandem repeats.Hum Genet,1993,91:403-404.
  • 10Mustea A,Sehouli J,Konsgen D,et al.Interleukin-1 receptor antagonist polymorphism in women with cervical canecr.Anticancer Res,2003,239:1099-1102.

二级参考文献29

  • 1刘志红,陈朝红,关天俊,王庆文,俞雨生,唐政,黎磊石.IgA肾病患者白细胞介素1受体拮抗剂和肿瘤坏死因子基因多态性分析[J].中华医学杂志,1997,77(2):145-146. 被引量:3
  • 2李璞主编.医学遗传学[M].重庆:重庆大学出版社,1993.193.
  • 3Hunley TE, Julian BA, Phillips JA, et al. Angiotensin converting enzyme polymorphism:potential silencer motif and impact on progression in igA nephropathy[ J] .Kidney Int, 1996,49:571.
  • 4Johnson RJ. The glomerular response to injury: progression or resolution?[J]Kidney Int,1994,45:1769
  • 5Blakemore AI, Tarlow JK, Cork MJ. Interleukin - 1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus[J]. Arthritis Rheum, 1994,37(9) : 1380.
  • 6Blakemore AI, Cox A, Gonzalez AM.Interleukin - 1 receptor antagonist allele (ILIRN * 2) associated with nephropathy in diabetes mellitus[ J]. Hum Genet, 1996,97(3) :369.
  • 7Hacker U T. Gomolka M, Keller E. Lack of association between an interleukin - 1 receptor antagonist gene polymorphism and ulcerative colitis[J].1997,40(5) :623.
  • 8Miller SA, Dykes DD, Polesky FIF, et al. A simple salting out procedure for extracting DNA from human nucleated cells [ J ]. Nucleic Acids Res,.1988,16(3):1215.
  • 9Dinarello CA. Biologic basis for interleukin-1 in disease. Blood,1996,87(6) :pp2095-2147.
  • 10Tarlow JK, Blakemore AIF, Lennard A,et al. Polymorphism in the human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bptandem repeat. Hum Genet, 1993,91(4) :403 -404.

共引文献23

同被引文献29

  • 1Huang D. Polymorphism in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis [J]. J Neuroimmunol, 1998,81 ( 1/2 ) : 71-86.
  • 2Bernard GR, Vincent JL, Latterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis[J]. N Engl J Med,2001,334(13) :699-709.
  • 3Gordon AC, Lagan AIr, Lagar Air, et al. TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study[J]. Genes and Immunity, 2004, 5 (8) : 631- 640.
  • 4Pillay V, Caillard MC, Halkas A. Differences in the genotypes and plasma concentration of the interkeukin-1 receptor antagonist in black and white South African asthmatics and control subjects[J]. Cytokine,2000,12(6) :819-821.
  • 5Arnalich F, Lopez Maderuelo D, Codoceo R. IL-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis[J]. Clin Exp Immunol, 2002,127 (2) : 331-336.
  • 6Pociot F,Wilson AG,Nerup J,et al. No independent association between a tumor necrosis faetor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus[J]. Eur J Immunol,1993,23(11) :3050-3053.
  • 7Bone RC. Toard an epidemiolog and natural history of SIRS (Sysiternic inflammatory response syndrome)[J].JAMA,1992,268(24):3452.
  • 8Bioque G, Crusius JBA , Koutroubakis I , et al . Allelic polymorphism in IL-113and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease[J]. Clin Exp Immunol, 1995, 102(2):379.
  • 9Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis[J]. N Engl J Med, 2001, 344(10):699.
  • 10Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in theUnited States: analysis of incidence, outcome, and associated costs of care[J]. Crit Care Med, 2001, 29(7): 1303.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部